Phase 3 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 80 years old
- People who have been diagnosed with a type of blood cancer called acute myeloid leukemia, confirmed through bone marrow testing, and where doctors strongly suspect a specific subtype called acute promyelocytic leukemia (APL)
Who may not be able to join:
- People whose testing (including chromosome analysis and a specific gene test) has confirmed that their leukemia is not the APL subtype — meaning the PML-RARα gene change was not found
- People with serious liver or kidney problems that are not caused by the leukemia itself — for example, certain blood markers for liver or kidney function being well above the normal range (confirm with trial site for specific thresholds)
- People with serious heart problems, such as reduced heart pumping function below a certain level (confirm with trial site)
- People who have another type of cancer at the same time
- Women who are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8618991232410
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Early Death Rate; Early death rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.